Jeffery Becker

Chief Scientific Officer

Dr. Becker has over 20 years of research and clinical experience in NMDA-receptor pharmacology and clinical use. He was one of the first MDs in U.S. administering and documenting ketamine for depression in the clinic, and is a world recognized speaker and expert in the clinical use of ketamine. His expertise led to development of an effective nutraceutical product addressing NMDA-receptor abnormalities. He received his B.S. from UC Berkeley and M.D from UCLA. He maintains a clinical practice focused in Functional Psychiatry and novel treatment approaches to mental health challenges.

Roles at Bexson Biomedical

  • Chief Scientific Officer

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Bexson Biomedical

My pet peeves

My communication style


No teams